Financials
- Market Capitalization 4.5 M
- Employee 19
- Founded 1988
- CEO David A. Dodd
- Website www.geovax.com
- Headquarter Delaware, United States
- FIGI BBG000BGGJD8
- Industry Biotechnologies
Chiffre d'affaires total
Résultat net
Bénéfice par action de base (BPA de base)
Dette totale
Flux de trésorerie disponible
Trésorerie et équivalents de trésorerie
ratio cours/bénéfice
-0.08
ratio cours/chiffre d'affaires
—
Related tickers
| # | Nom | Prix | 24h % | 7 jours % | 1M % | 1 an % | Cap Boursière | 7 Derniers Jours | |
|---|---|---|---|---|---|---|---|---|---|
| 4936 | EVGN Evogene Ltd. - Ordinary Shares | 0.52 USD | -3.70% | -3.70% | +6.12% | -58.40% | 4.53 M USD | ||
| 4938 | ADXN Addex Therapeutics Ltd - American Depositary Shares | 3.65 USD | -6.89% | -17.61% | -36.52% | -52.90% | 4.50 M USD | ||
| 4941 | BTAI BioXcel Therapeutics, Inc. - Common Stock | 0.14 USD | -12.50% | -81.58% | -82.72% | -91.14% | 4.38 M USD | ||
| 4946 | INM InMed Pharmaceuticals Inc. - Common Shares | 1.32 USD | -2.22% | -6.38% | -10.20% | -38.60% | 4.37 M USD |